Gemcitabine plus cisplatin vs S‐1 plus cisplatin
Overall response rate · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine plus cisplatin changes overall response rate compared with S‐1 plus cisplatin (very low certainty).
1 finding from 1 review
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes onlyRR 0.82 [0.37, 1.82]1 study · 88 participantsVery low